EcoDrugPlus

Prostaglandin E Receptor 1

Ensembl ID : ENSBBBG00000020190
Gene Symbol: PTGER1
3 Cross references
237 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSBBBG00000025180
Gene Symbol: PTGER2
3 Cross references
244 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSBBBG00000012819
Gene Symbol: PTGER3
3 Cross references
196 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSBBBG00000025021
Gene Symbol: PTGER4
3 Cross references
275 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSBBBG00000012278
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSBBBG00000014585
Gene Symbol: PTGIR
3 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSBBBG00000012500
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSBBBG00000023652
Gene Symbol: PTGS2
3 Cross references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSBBBG00000014567
Gene Symbol: PSMA1
3 Cross references
241 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSBBBG00000007372
Gene Symbol: PSMA2
3 Cross references
218 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSBBBG00000020117
Gene Symbol: PSMA3
3 Cross references
246 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSBBBG00000008487
Gene Symbol: PSMA4
2 Cross references
237 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).